Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-10-2023 | Case report

Bleomycin/cisplatin/etoposide

Neutropenic fever: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Pfister D, et al. Complications During Cisplatin Based Primary Chemotherapy in Patients with Testicular Cancer: is There a Need for Thromboembolic Prophylaxis. Annals of Oncology 25 (Suppl. 4): iv299 abstr. 858P, Sep 2014. Available from: URL: http://doi.org/10.1093/annonc/mdu337.51 [abstract] Pfister D, et al. Complications During Cisplatin Based Primary Chemotherapy in Patients with Testicular Cancer: is There a Need for Thromboembolic Prophylaxis. Annals of Oncology 25 (Suppl. 4): iv299 abstr. 858P, Sep 2014. Available from: URL: http://​doi.​org/​10.​1093/​annonc/​mdu337.​51 [abstract]
Metadata
Title
Bleomycin/cisplatin/etoposide
Neutropenic fever: case report
Publication date
01-10-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-47827-9

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Adalimumab

Case report

Olanzapine

Case report

Denosumab

Case report

Antithrombotics

Case report

Memantine